Cargando…

Post-exposure treatment of non-human primates lethally infected with Ebola virus with EBOTAb, a purified ovine IgG product

Despite sporadic outbreaks of Ebola virus (EBOV) over the last 4 decades and the recent public health emergency in West Africa, there are still no approved vaccines or therapeutics for the treatment of acute EBOV disease (EVD). In response to the 2014 outbreak, an ovine immunoglobulin therapy was de...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dowall, Stuart D., Jacquot, Frédéric, Landon, John, Rayner, Emma, Hall, Graham, Carbonnelle, Caroline, Raoul, Hervé, Pannetier, Delphine, Cameron, Ian, Coxon, Ruth, Al Abdulla, Ibrahim, Hewson, Roger, Carroll, Miles W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5481440/ https://www.ncbi.nlm.nih.gov/pubmed/28642489 http://dx.doi.org/10.1038/s41598-017-03910-7

Ejemplares similares

Post-exposure treatment of Ebola virus disease in guinea pigs using EBOTAb, an ovine antibody-based therapeutic
por: Dowall, Stuart D., et al.
Publicado: (2016)

Development of a Cost-effective Ovine Polyclonal Antibody-Based Product, EBOTAb, to Treat Ebola Virus Infection
por: Dowall, Stuart David, et al.
Publicado: (2016)

Ebola viral dynamics in nonhuman primates provides insights into virus immuno-pathogenesis and antiviral strategies
por: Madelain, Vincent, et al.
Publicado: (2018)

Effective Binding of a Phosphatidylserine-Targeting Antibody to Ebola Virus Infected Cells and Purified Virions
por: Dowall, S. D., et al.
Publicado: (2015)

A Novel Vaccine against Crimean-Congo Haemorrhagic Fever Protects 100% of Animals against Lethal Challenge in a Mouse Model
por: Buttigieg, Karen R., et al.
Publicado: (2014)

Minimal In Vivo Efficacy of Iminosugars in a Lethal Ebola Virus Guinea Pig Model
por: Miller, Joanna L., et al.
Publicado: (2016)

Antiviral efficacy of favipiravir against Ebola virus: A translational study in cynomolgus macaques
por: Guedj, Jérémie, et al.
Publicado: (2018)

A Crimean-Congo hemorrhagic fever (CCHF) viral vaccine expressing nucleoprotein is immunogenic but fails to confer protection against lethal disease
por: Dowall, SD, et al.
Publicado: (2015)

A Single Dose of Modified Vaccinia Ankara expressing Ebola Virus Like Particles Protects Nonhuman Primates from Lethal Ebola Virus Challenge
por: Domi, Arban, et al.
Publicado: (2018)

Investigating the Cellular Transcriptomic Response Induced by the Makona Variant of Ebola Virus in Differentiated THP-1 Cells
por: Bosworth, Andrew, et al.
Publicado: (2019)

A thermostable, chromatographically purified Ebola nano-VLP vaccine
por: Carra, John H, et al.
Publicado: (2015)

Antibody Quality and Protection from Lethal Ebola Virus Challenge in Nonhuman Primates Immunized with Rabies Virus Based Bivalent Vaccine
por: Blaney, Joseph E., et al.
Publicado: (2013)

Elucidating variations in the nucleotide sequence of Ebola virus associated with increasing pathogenicity
por: Dowall, Stuart D, et al.
Publicado: (2014)

Impact of intensive care unit supportive care on the physiology of Ebola virus disease in a universally lethal non-human primate model
por: Poliquin, Guillaume, et al.
Publicado: (2019)

Postexposure protection of non-human primates against a lethal Ebola virus challenge with RNA interference: a proof-of-concept study
por: Geisbert, Thomas W, et al.
Publicado: (2010)

Refinement of an ovine-based immunoglobulin therapy against SARS-CoV-2, with comparison of whole IgG versus F(ab′)(2) fragments
por: Findlay-Wilson, Stephen, et al.
Publicado: (2023)

Successful post-exposure prophylaxis of Ebola infected non-human primates using Ebola glycoprotein-specific equine IgG
por: Pyankov, Oleg V., et al.
Publicado: (2017)

Development of vaccines against Crimean-Congo haemorrhagic fever virus
por: Dowall, Stuart D., et al.
Publicado: (2017)

Correction to: Impact of intensive care unit supportive care on the physiology of Ebola virus disease in a universally lethal non-human primate model
por: Poliquin, Guillaume, et al.
Publicado: (2019)

Publisher Correction: Refinement of an ovine-based immunoglobulin therapy against SARS-CoV-2, with comparison of whole IgG versus F(ab′)(2) fragments
por: Findlay‑Wilson, Stephen, et al.
Publicado: (2023)

Evaluation in Nonhuman Primates of Vaccines against Ebola Virus
por: Geisbert, Thomas W., et al.
Publicado: (2002)

Euthanasia Assessment in Ebola Virus Infected Nonhuman Primates
por: Warren, Travis K., et al.
Publicado: (2014)

Adenoviral vectored vaccination protects against Crimean-Congo Haemorrhagic Fever disease in a lethal challenge model
por: Saunders, Jack E., et al.
Publicado: (2023)

Purifying selection shapes the coincident SNP distribution of primate coding sequences
por: Chen, Chia-Ying, et al.
Publicado: (2016)

A Single Dose Respiratory Recombinant Adenovirus-Based Vaccine Provides Long-Term Protection for Non-Human Primates from Lethal Ebola Infection
por: Choi, Jin Huk, et al.
Publicado: (2014)

Favipiravir pharmacokinetics in Ebola-Infected patients of the JIKI trial reveals concentrations lower than targeted
por: Nguyen, Thi Huyen Tram, et al.
Publicado: (2017)

Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp(™)
por: Qiu, Xiangguo, et al.
Publicado: (2014)

Transmission of Ebola virus from pigs to non-human primates
por: Weingartl, Hana M., et al.
Publicado: (2012)

Antiviral Screening of Multiple Compounds against Ebola Virus
por: Dowall, Stuart D., et al.
Publicado: (2016)

Ebola GP-Specific Monoclonal Antibodies Protect Mice and Guinea Pigs from Lethal Ebola Virus Infection
por: Qiu, Xiangguo, et al.
Publicado: (2012)

Efficient infection of non-human primates with purified, cryopreserved Plasmodium knowlesi sporozoites
por: Chakravarty, Sumana, et al.
Publicado: (2022)

Protective effects of a Modified Vaccinia Ankara-based vaccine candidate against Crimean-Congo Haemorrhagic Fever virus require both cellular and humoral responses
por: Dowall, Stuart D., et al.
Publicado: (2016)

Cytomegalovirus-based vaccine expressing Ebola virus glycoprotein protects nonhuman primates from Ebola virus infection
por: Marzi, Andrea, et al.
Publicado: (2016)

A Multi-Filovirus Vaccine Candidate: Co-Expression of Ebola, Sudan, and Marburg Antigens in a Single Vector
por: Sebastian, Sarah, et al.
Publicado: (2020)

Development of a cost-effective ovine antibody-based therapy against SARS-CoV-2 infection and contribution of antibodies specific to the spike subunit proteins
por: Findlay-Wilson, Stephen, et al.
Publicado: (2022)

Comparative Transcriptomics in Ebola Makona-Infected Ferrets, Nonhuman Primates, and Humans
por: Cross, Robert W, et al.
Publicado: (2018)

Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates
por: Sullivan, Nancy J., et al.
Publicado: (2003)

Natural history of nonhuman primates after conjunctival exposure to Ebola virus
por: Cross, Robert W., et al.
Publicado: (2023)

Extracellular vesicle storm during the course of Ebola virus infection in primates
por: Vucetic, Andrea, et al.
Publicado: (2023)

Purified Inactivated Zika Vaccine Candidates Afford Protection against Lethal Challenge in Mice
por: Baldwin, Whitney R., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_9o1lkfeugh5nufs6lhhjrag7p8